BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang J, Liu J, He C, Sun T, Yan Y, Che G, Li X, Sun H, Ma H. Trends in Incidence and Survival of Patients with Pancreatic Neuroendocrine Neoplasm, 1987-2016. J Oncol 2021;2021:4302675. [PMID: 34976056 DOI: 10.1155/2021/4302675] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Yang DH, Cheng J, Tian XF, Zhang Q, Yu LY, Qiu YJ, Lu XY, Lou WH, Dong Y, Wang WP. Prediction of Pathological Grades of Pancreatic Neuroendocrine Tumors Based on Dynamic Contrast-Enhanced Ultrasound Quantitative Analysis. Diagnostics (Basel) 2023;13. [PMID: 36673048 DOI: 10.3390/diagnostics13020238] [Reference Citation Analysis]
2 Liu X, Chen B, Chen J, Su Z, Sun S. The incidence, prevalence, and survival analysis of pancreatic neuroendocrine tumors in the United States. J Endocrinol Invest 2022. [DOI: 10.1007/s40618-022-01985-2] [Reference Citation Analysis]
3 Lu Z, Li T, Liu C, Zheng Y, Song J. Development and validation of a survival prediction model and risk stratification for pancreatic neuroendocrine neoplasms. J Endocrinol Invest 2022. [DOI: 10.1007/s40618-022-01956-7] [Reference Citation Analysis]